Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Daiichi Sankyo Launches PI for DS-6157 for GIST; 5th ADC Entered in Clinical Stage
May 25, 2020
- As Beovu Debut Nears, Novartis Set to Push Longer Dosing Interval, Pivotal Data in Battle against Eylea
May 22, 2020
- GSK Japan Looking to Develop Otilimab for COVID-19; President Stresses Efforts on Vaccines, Disease Management Too
May 22, 2020
- No. of Ambulatory Patients Sags 6% in March amid COVID-19, Greater Drop in Special Alert Prefectures: Survey
May 22, 2020
- EMA Accepts Roxadustat for Review
May 22, 2020
- Nippon Shinyaku’s DMD Drug Now Available in Japan; AZ’s Lokelma, Ono’s Velexbru Too
May 21, 2020
- Zolgensma Hits Japan Market with Stringent Conditions Attached
May 21, 2020
- Nipro to Roll Out Symbicort Copy in June with Stable Supply System in Place
May 21, 2020
- Suzuken to Exclusively Distribute Novartis’ Zolgensma in Japan
May 21, 2020
- JCR Chief Delays Global Licensing Timeline for Lysosomal Storage Disorder Therapies
May 20, 2020
- Astellas Confident of Hitting 3-Year Biz Goals on Xtandi, Full Backing of New Products
May 20, 2020
- Stella Pharma Launches New Cancer Radiation Therapy Steboronine
May 20, 2020
- Sawai, Nichi-Iko Hint at Delay in Edirol Generic Debut
May 20, 2020
- Astellas Eases Work-from-Home Policy in 39 Prefectures after Partial COVID-19 Emergency Lift
May 20, 2020
- JCR Aims to File Sakigake-Designated Hunter Syndrome Drug in September
May 19, 2020
- Mitsubishi Tanabe, Fuso to Copromote HIF-PH Inhibitor
May 19, 2020
- Nichi-Iko Launches Another Recall, Now Pulling 8 More APIs/9 Products
May 19, 2020
- Medicago’s COVID-19 Vaccine Shows Positive Animal Data, Clinical Trial Expected to Wrap Up by November 2021
May 19, 2020
- Enhertu Gets FDA’s Breakthrough Therapy Status for NSCLC
May 19, 2020
- Japan Ethical Drug Sales Down 2.9% in March: Crecon
May 18, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…